Download Gita Shafiee

Gita Shafiee
Academic
MD, MPH
University:
Tehran University of Medical Sciences (TUMS)
Hospital/Ward: Shariati/Internal endocrinologic
Address:
Endocrinology and Metabolic Research Institute ,5th floor, Shariati
Hospital ,Karegar st.,Tehran ,Iran
Tel:
Fax :
E-mail:
+9821-88220038
+9821-88220052
[email protected]
Academic Qualification
1. 2009: MPH (Master Public Health) at Shaheed Beheshti Medical University
2. 1996: MD at Isfahan (Kashan) university of medical sciences.
Selected Courses and Workshops
1. Training workshop of “A 3-day Hands-on Training on essentials in Cell and
Molecular Biology Techniques”, Endocrinology and Metabolic Research Institute,
2012
2. Workshop on “Scientific Presentation”,2012
3.
Seminar on “Diabetes and its complications”, 2012
4. Course “ 4th course of teaching Diabetes”, 2012
5. Workshop on “Good Clinical Practice (GCP), 2010- Istanbul.
6. Workshop on “ENDNOTE” software, 2010.
7. Workshop on “STATA” software, 2010.
8. Workshop on “Control and Prevention of Diabetes”, 2010.
9. Completed the course: Obesity, a guide to prevention and management, BMJ
Learning: 2010.
10. Workshop on “Clinical Appraisal & Peer Review”, 2007.
11. Workshop on “Medical Writing”, 2007
12. Workshop on “Regression Analysis”, 2007.
13. Workshop on “Design & Analysis of Survival Study”, 2007.
14. Workshop on “SPSS” software, 2006.
15. Workshop on “Advanced Research Methodology”, 2006.
16. Workshop on “Description Research Methodology”, 2005.
17. Workshop on “Control and Management of Diabetes”, 2004.
Professional Experience
1. Executive Secretary in Chronic Diseases Research Center (CDRC), Endocrinology and
Metabolism Research Institute (EMRI), Tehran University of Medical Sciences (TUMS)
(2012 to present)
2. Research Assistant in Endocrinology and Metabolism Research Institute (EMRI), Tehran
University of Medical Sciences (TUMS) (2011 to present)
3. Research Assistant in Endocrinology - “Institute of Endocrinology & Metabolism”:
Tehran University of Medical Sciences (2009-2011).
4. Medical consultant of Hafez Insurance Company (2005-2011)
5. Researcher of “Prevention of Metabolic Disorders Research Center”: Shaheed
Beheshti Medical University (2007-2010)
6. Medical consultant of Kar Afarin Insurance Company (2005-2010)
7. Head of section treatment at Tehran Lipid & glucose center (2005-2007)
8. Physician at Tehran Lipid & glucose center (1999-2005)
9. Physician at an urban clinic (1996-1999)
10. Head of cultural clinic (1997-1998)
11. Lecturer: teaching in family health education (1996-1998)
Articles
1. First Report on Validity of a Continuous Metabolic Syndrome Score as An Indicator
for Metabolic Syndrome Syndrome in A National Sample of Pediatric Population: the
CASPIAN-III Study. Shafiee G, Kelishadi R , Heshmat R, Qorbani M, Motlagh M.E,
Aminaee T, Ardalan G, Taslimi M, Poursafa P , Larijani B. Polish Journal of
Endocrinology, 2013, Issue 3. [Epub ahead of print]
2. Association of breakfast intake with cardiometabolic risk factors in a nationallyrepresentative sample of Iranian children and adolescents: the CASPIAN-III Study.
Shafiee G, Kelishadi R , Heshmat R, Qorbani M, Motlagh M.E, Aminaee T, Ardalan
G, Taslimi M, Poursafa P , Larijani B. J International Preventive Medicine, 2013,.
[Epub ahead of print]
3. Dual Burden of Body Weight among Iranian Children and Adolescents in 2003-2008:
The CASPIAN-III Study. Rahmanian M, Kelishadi R, Qorbani M, Motlagh M.E,
Shafiee G, Aminaee T, Ardalan G, Taslimi M, Poursafa P , Larijani B, Heshmat R.
Archives of Med Sci, 2013,. [Epub ahead of print]
4. Association of anthropometric measures with cardiovascular risk factors and
metabolic syndrome in normal-weight children and adolescents: CASPIAN III Study.
Qorbani M , Kelishadi R, Farrokhi-Khajeh-Pasha Y, Motlagh M.E , Aminaee T, Ardalan G,
Asayesh H, Shafiee G, Taslimi M, Poursafa P, Heshmat R, Larijani B. Obesity Facts, 2013,.
[Epub ahead of print]
5. Alteration of pulmonary function in diabetic nephropathy. Shafiee G, Khamseh ME,
Rezaei N, Aghili R, Malek M. J Diabetes Metab Disord. 2013;12: 15
6. Effects of Ramadan fasting on metabolic outcomes in fasting diabetic subjects.
Khamseh M.E, Aghili R, Malek M, Shafiee G, Zarghami S.Y, Baradaran HR .
Komesh 2013;14:145-151.
7. Randomized clinical trial comparing lightweight mesh with heavyweight mesh for
primary inguinal hernia repair.Yazdankhah Kenary A, Afshin SN, Ahmadi Amoli H,
Yagoobi Notash A, Borjian A, Yagoobi Notash Jr A, Shafaattalab S, Shafiee G.
Hernia. 2012 Nov 9. [Epub ahead of print]
8. The importance of hypoglycemia in diabetic patients. Shafiee G, Mohajeri-Tehrani
MR, Pajouhi M, Larijani B. Journal of Diabetes & Metabolic Disorders 2012, 11:17.
9. Does an electrocardiogram add predictive value to the rose angina questionnaire for
future coronary heart disease? 10-year follow-up in a Middle East population.Khalili
D, Hadaegh F, Fahimfar N, Shafiee G, Sheikholeslami F, Ghanbarian A, Azizi F.J
Epidemiol Community Health. 2012; 66(12):1104-9.
10. A thirty-year analysis of cesarean section rate in gestational diabetes and normal
pregnant population in Tehran, Iran: a concerning trend. Badakhsh MH, Khamseh
ME, Malek M, Shafiee G, Aghili R, Moghimi S, Baradaran HR, Seifoddin M.
Gynecol Endocrinol. 2012; 28(6):436-9
11. Systolic and diastolic blood pressure, mean arterial pressure and pulse pressure for
prediction of cardiovascular events and mortality in a Middle Eastern population.
Hadaegh F, Shafiee G, Hatami M, Azizi F. Blood Press. 2012; 21(1):12-8.
12. Quality of life in patients with type 1 diabetes. Khamseh ME, Monavari A, Malek M,
Shafiee G, Baradaran H. Iranian Journal of Endocrinology & Metabolism 2011,
13(3): 249-255.
13. Effects of a structured self-monitoring of blood glucose method on patient selfmanagement behavior and metabolic outcomes in type 2 diabetes mellitus. Khamseh
ME, Ansari M, Malek M, Shafiee G, Baradaran H. J Diabetes Sci Technol.
2011;5(2):388-93
14. Impact of maternal zinc status on fetal growth in an Iranian pregnant
population.Badakhsh MH, Khamseh ME, Seifoddin M, Kashanian M, Malek M,
Shafiee G, Baradaran HR. Gynecol Endocrinol. 2011; 27(12):1074-6
15. Relationship between patients' perception of the importance of diabetes and metabolic
control and pursuing chronic complications of disease. Khamseh ME, Abdi H,
Malek M, Shafiee G, Khodakarim S. Koomesh 2011, 12(3): 334-341.
16. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events:
Tehran lipid and glucose study. Hadaegh F, Shafiee G, Ghasemi A, Sarbakhsh P,
Azizi F. Diabetes Res Clin Pract 2010; 87(3):342-7.
17. Anthropometric predictors of incident type 2 diabetes mellitus in Iranian women.
Hadaegh F, Shafiee G, Azizi F. Ann Saudi Med 2009; 29(3):194-200.
18. Comparison of Waist-to-Height Ratio and Body Mass Index for Prediction of Type 2
Diabetes Mellitus Risk in Women: Tehran Lipid and Glucose Study .Shafiee G,
Hadaegh F, Azizi F. Iranian Journal of Endocrinology & Metabolism 2009; 11 (1):
17-24.
19. Comparison of ECG abnormalities in chronic kidney disease and diabetes mellitus:
Tehran Lipid and Glucose(TLGS), Ghanbarian A, shafiee G, Rashidi A, Azizi F,
Iranian journal of endocrinology & metabolism 2005; 7(4), 449-457.
20. Blood pressure measures and ECG-defined
myocardial infarction in an Iranian
population: Tehran Lipid and Glucose, Ghanbarian A, Rezaei- Ghaleh N, Haj
Sheikholeslami F, Habibi Moini AS, Shafiee G, Kallhor Y, Azizi F, Iranian journal of
endocrinology & metabolism 2004; 6( 1),63-69.
21. Directional Agreement Between Rose Angina and ECG-Defined Coronary Heart
Disease in an Iranian Urban Population: “Tehran Lipid and Glucose Study”
Rezaeighaleh N, Ghanbarian A, Etemadi A, Momenan AA, Shafiee G, Azizi F. ,
Iranian journal of endocrinology & metabolism 2003; 5(4), 437-445.
Selected Presentations
1. Frequent occurrence of hypogonadism in men with type 2 diabetes. The 4th
International Diabetes Update Congress. Iran, Tehran 29 Feb- 2 May, 2012
2. The effects of vitamin C and vitamin E supplementation on the metabolic profile and
antioxidants in type 2 diabetes. The 4th International Diabetes Update Congress. Iran,
Tehran 29 Feb- 2 May, 2012.
3. Pulmonary function in type 2 diabetic patients with nephropathy. The 9th International
Congress of Endocrine Disorders. Iran, Tehran, November, 15-18, 2011
4. Impact of metabolic syndrome, diabetes and pre-diabetes on cardiovascular
events: Tehran Lipid and Glucose Study. The 8th International Congress of
Endocrine Disorders & the 2nd Arab-Iran Congress of Endocrinology and Diabetes,
Iran,Tehran, October, 27-29, 2009.
5. Blood pressure and the risk of cardiovascular disease among Iranian: Tehran Lipid
and Glucose Study. The 8th International Congress of Endocrine Disorders & The 2nd
Arab-Iran Congress of Endocrinology and Diabetes, Iran, Tehran, October, 27-29,
2009.
6. Anthropometric predictors of incident type 2 diabetes mellitus in Iranian women. The
8th International Congress of Endocrine Disorders & the 2nd Arab-Iran Congress of
Endocrinology and Diabetes, Iran, Tehran, October, 27-29, 2009.
7. Prevalence of poly cystic ovary and idiopathic hirsutism in women 15-45 years.7th
International Congress of Endocrine Disease, Iran, Tehran, 2004.
8. Dietary patterns of urban Tehran and Risk factors of non-communicable diseases:
Tehran Lipid & Glucose Study. Second Congress of Prevention of Noncommunicable Diseases, Iran, Tehran 2003.
Ongoing research Projects
1. Assessment of practical plans and studies in the field of diabetes research in the world
along with purposeful classification(2013).
2. Effect of a Aphanizomenon Flos-aquae extract on mobilization of bone marrow stem
cells and metabolic profile of patients with type 2 diabetes (2013).
3. National and subnational trends in metabolic syndrome prevalence from 1990 to 2012
in Iran and study of its burden and suggest an appropriate prediction model (2013).
4. Association of adiponectine gene polymorphism with endometrial cancer (2012).
5. SERPINA 12 gene and vaspin serum concentrations in polycystic ovary syndrome
(2012)
6. Pulmonary function in diabetic patients with nephropathy (2011).
7. The development and validation of a diabetes medication satisfaction questionnaire
for patients with type 2 diabetes having oral agent drugs (OADs) (2011).
8. The development and validation of a diabetes-specific Health- related quality of life
questionnaire for patients with type 1 diabetes (2011).
9. Metabolic profile in prolactinoma patients before and after normalization of prolactin
by dopamine agonist therapy in Dr. Shariati Hospital (2011).
10. Establishing a clinical information system records and briefs in endocrine diseases in
Dr. Shariati hospital (2011)
11. Evaluation cardiovascular risk factors and carotid intima-media thickness in patients
with Cushing’s syndrome during active disease and after remission (2011).
12. Rose questionnaire and Electrocardiography in predicting the incidence of coronary
artery disease: Tehran Lipid and Glucose Study (2010).
13. Systolic Blood Pressure and Other Blood Pressure Measures as Predictors of
Cardiovascular Disease Risk: Tehran Lipid and Glucose Study (2009).
14. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events:
Tehran Lipid and Glucose Study(2009)
15. Waist-to-height ratio is a superior predictor than body mass index of type 2 diabetes
mellitus risk in women: Tehran Lipid and Glucose Study (2008).
Co-Investigator:
1. Evaluating clinical practice of general practitioners regarding management and
control of type 2 diabetes mellitus, IUMS (2009).
2. Tehran Lipid & Glucose Study, National Study: (1998-2009).
3. Polycystic ovary syndrome , Hirsutism (2004)
Sub- Investigator:
1. Early introduction of insulin Glargine in type 2 diabetic patients in adequately
controlled on 2 OADs- Sanofi Aventis Company.
2. Nephropathy Study- Sanofi Aventis Company.
3. The A1chieve Study- Novo Nordisk Company.
Selected books- booklets:
1. Gland
diseases
patients
education
series:
Hyperprolactinemia.
Tehran:
Endocrinology and Metabolism Research Institute, 2013
2. Gland diseases patients education series: Cushing. Tehran: Endocrinology and
Metabolism Research Institute, 2013
3. Gland diseases patients education series: Acromegaly. Tehran: Endocrinology and
Metabolism Research Institute, 2013
4. Gland diseases patients education series: Hormones & Hypertension. Tehran:
Endocrinology and Metabolism Research Institute, 2013
5. Gland diseases patients education series: Diabetes Insipidus. Tehran: Endocrinology
and Metabolism Research Institute, 2013
6. Gland diseases patients education series: Polycystic Ovary Syndrome. Tehran:
Endocrinology and Metabolism Research Institute, 2013
7. Gland diseases patients education series: Hirsutism. Tehran: Endocrinology and
Metabolism Research Institute, 2013
8. The National and Regional Guideline of Prevention, Diagnosis, and Management of
Hirsutism. Tehran: Endocrinology and Metabolism Research Institute, in press, 2013